FDA Awards $1.5 Million Grant to ADA Science and Research Institute
ADASRI, University of Pittsburgh to develop pain management guidelines in dentistry with focus on role of opioids.
The U.S. Food and Drug Administration has awarded a 3-year, $1.5 million grant to the American Dental Association (ADA) Science & Research Institute, LLC (ADASRI) in collaboration with the University of Pittsburgh to develop a clinical practice guideline for the management of acute pain in dentistry with a focus on the role of opioids.
ADASRI will work with the University of Pittsburgh to develop, disseminate, implement, and evaluate a national clinical practice guideline for the management of acute pain in dentistry. Alonso Carrasco-Labra, DDS, MSc, PhD, senior director of ADASRI Evidence Synthesis and Translation Research, and Deborah Polk, PhD, assistant professor of dental public health in the School of Dental Medicine at the University of Pittsburgh, will serve as the project’s co-principal investigators.
This is the first grant awarded to ADASRI’s Evidence Synthesis and Translation Research team since the official launch of ADASRI in January 2020. This award adds to the growing list of ADASRI grant awards for 2020, which includes three National Institutes of Health grants awarded to the ADASRI Innovation and Technology Research team.
For more information on how the ADA is working to combat opioid abuse, while continuing to help patients manage dental pain, visit www.ADA.org/opioids. For more information on ADASRI, visit www.ADA.org/SRI.
